Article Information
History
- December 9, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Yaqi Zhao1,2,*,
- Nicholas J Short3,*,
- Hagop M Kantarjian3,
- Ti-Cheng Chang4,
- Pankaj S Ghate1,2,
- Chunxu Qu1,2,
- Walid Macaron3,
- Nitin Jain3,
- Beenu Thakral5,
- Aaron H Phillips6,
- Joseph Khoury7,
- Guillermo Garcia-Manero3,
- Wenchao Zhang4,
- Yiping Fan4,
- Hui Yang3,
- Rebecca S Garris3,
- Lewis F Nasr3,
- Richard W Kriwacki6,
- Kathryn G Roberts1,2,
- Marina Konopleva8,
- Elias J Jabbour3,** and
- Charles G Mullighan1,2,**,#
- 1Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN
- 2Center of Excellence for Leukemia Studies, St. Jude Children’s Research Hospital, Memphis, TN
- 3Department of Leukemia, MD Anderson Cancer Center, Houston, TX
- 4Center for Applied Bioinformatics, St. Jude Children’s Research Hospital, Memphis, TN
- 5Department of Hematopathology, MD Anderson Cancer Center, Houston, TX
- 6Department of Structural Biology, St. Jude Children’s Research Hospital, Memphis, TN
- 7Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
- 8Department of Medicine/Oncology and Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY
- ↵#Corresponding author; email: charles.mullighan{at}stjude.org
Posted December 09, 2023.
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL
